Plotkin S Vaccines Eighth Edition
Human Immunodeficiency Virus Vaccines
Publication
, Chapter
Haynes, BF; Wiehe, K; Acharya, P; Saunders, KO
January 1, 2023
HIV-1 vaccine development is a critical global health priority. The reasons why we do not have an HIV-1 vaccine as yet are many, including a dense envelop glycan shield, rare neutralizing B cell precursors, the need for improbable neutralizing antibody mutations, and disfavored protective antibodies by immune tolerance mechanisms. Current work is ongoing to design strategies to overcome these roadblocks in vaccine design include targeting the naive B cell receptors of rare broadly neutralizing antibody clonal lineages, and design of sequential immunogens to lead or guide protective antibody development. In addition, T cell immunogens are being designed to induce broad cytotoxic T cell responses to overcome HIV-1 diversity.
Duke Scholars
DOI
Publication Date
January 1, 2023
Start / End Page
458 / 483.e15
Citation
APA
Chicago
ICMJE
MLA
NLM
Haynes, B. F., Wiehe, K., Acharya, P., & Saunders, K. O. (2023). Human Immunodeficiency Virus Vaccines. In Plotkin S Vaccines Eighth Edition (pp. 458-483.e15). https://doi.org/10.1016/B978-0-323-79058-1.00031-1
Haynes, B. F., K. Wiehe, P. Acharya, and K. O. Saunders. “Human Immunodeficiency Virus Vaccines.” In Plotkin S Vaccines Eighth Edition, 458-483.e15, 2023. https://doi.org/10.1016/B978-0-323-79058-1.00031-1.
Haynes BF, Wiehe K, Acharya P, Saunders KO. Human Immunodeficiency Virus Vaccines. In: Plotkin S Vaccines Eighth Edition. 2023. p. 458-483.e15.
Haynes, B. F., et al. “Human Immunodeficiency Virus Vaccines.” Plotkin S Vaccines Eighth Edition, 2023, pp. 458-483.e15. Scopus, doi:10.1016/B978-0-323-79058-1.00031-1.
Haynes BF, Wiehe K, Acharya P, Saunders KO. Human Immunodeficiency Virus Vaccines. Plotkin S Vaccines Eighth Edition. 2023. p. 458-483.e15.
DOI
Publication Date
January 1, 2023
Start / End Page
458 / 483.e15